It serves as the precursor for the “A-ring” portion (aromatic part) of the diarylmethane structure, which is subsequently coupled with a glucose-derived component to form the final active pharmaceutical ingredient. 5-Bromo-4-methoxy-2-methylbenzoic acid is a key raw material used in the industrial synthesis of Luseogliflozin (TS-071), a selective SGLT2 inhibitor used for treating type 2 diabetes.
5-Bromo-4-methoxy-2-methylbenzoic acid
| API Name | Luseogliflozin |
|---|---|
| CAS No | 875245-69-5 |
| Molecular Formula | C9H9BrO3 |
| Molecular Weight | 245.07 g/mol |
| Synonyms | 5-bromo-4-methoxy-2-methylbenzoic acid |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
It serves as the precursor for the "A-ring" portion (aromatic part) of the diarylmethane structure, which is subsequently coupled with a glucose-derived component to form the final active pharmaceutical ingredient. 5-Bromo-4-methoxy-2-methylbenzoic acid is a key raw material used in the industrial synthesis of Luseogliflozin (TS-071), a selective SGLT2 inhibitor used for treating type 2 diabetes.
The CAS number of 5-Bromo-4-methoxy-2-methylbenzoic acid is 875245-69-5.
The molecular formula of 5-Bromo-4-methoxy-2-methylbenzoic acid is C9H9BrO3.
The listed molecular weight of 5-Bromo-4-methoxy-2-methylbenzoic acid is 245.07 g/mol.
5-Bromo-4-methoxy-2-methylbenzoic acid is listed as being used in connection with the following API: Luseogliflozin.
The listed synonym or IUPAC name for 5-Bromo-4-methoxy-2-methylbenzoic acid is 5-bromo-4-methoxy-2-methylbenzoic acid.